Brief: Jazz Pharmaceuticals Expects To Meet 2024 Revenue Guidance
13/01/2025 13:51
Jan 13 (Reuters) - Jazz Pharmaceuticals PLC JAZZ.O :
* JAZZ PHARMACEUTICALS PLC - EXPECTS TO MEET 2024 REVENUE
GUIDANCE
Further company coverage: JAZZ.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Jazz Pharmaceuticals
See all newsBrief: Jazz Pharmaceuticals Enters Amendment No. 4 To Credit Agreement On Sept 23, 2026
U.S. STOCKS ON THE MOVE-BWX Technologies, Synopsys,Burlington Stores
U.S. STOCKS ON THE MOVE-Jazz Pharmaceuticals, Celularity, Infleqtion
Jazz Pharma dips after upsized $1.1 bln convertible offering
Brief: Jazz Pharmaceuticals Announces Private Offering Of $1.0 Billion Of Exchangeable Senior Notes Due 2032